UBS (Lux) Equity Fund - Biotech P Fonds
631,05
EUR
-5,30
EUR
-0,83
%
753,21
USD
+10,97
USD
+1,48
%
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 7,70% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 7,22% |
| Neurocrine Biosciences Inc | US64125C1099 | 5,09% |
| Guardant Health Inc | US40131M1099 | 4,92% |
| AbbVie Inc | US00287Y1091 | 4,50% |
| Gilead Sciences Inc | US3755581036 | 4,29% |
| Amgen Inc | US0311621009 | 4,16% |
| Sandoz Group AG Registered Shares | CH1243598427 | 4,08% |
| Denali Therapeutics Inc | US24823R1059 | 3,26% |
| Roivant Sciences Ltd Ordinary Shares | BMG762791017 | 3,24% |
| Sonstige | 51,55% |